Nivolumab/pembrolizumabVarious toxicities: 5 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2019年 / 1734卷 / 1期

关键词：

D O I：

10.1007/s40278-019-56504-5

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：379 / 379

相关论文

共 50 条

[41] Ipilimumab/nivolumab/pembrolizumabVarious toxicities: 10 case reports
Reactions Weekly, 2021, 1840 (1) : 227 - 227
[42] Atezolizumab/nivolumab/pembrolizumabVarious toxicities: 20 case reports
Reactions Weekly, 2025, 2042 (1) : 63 - 63
[43] Ipilimumab/nivolumab/pembrolizumabVarious toxicities: 4 case reports
Reactions Weekly, 2018, 1685 (1) : 117 - 117
[44] Ipilimumab/nivolumab/pembrolizumabVarious toxicities: 6 case reports
Reactions Weekly, 2021, 1849 (1) : 252 - 252
[45] Ipilimumab/nivolumab/pembrolizumabVarious toxicities: 8 case reports
Reactions Weekly, 2020, 1791 (1) : 153 - 153
[46] Ipilimumab/nivolumab/pembrolizumabVarious toxicities: 6 case reports
Reactions Weekly, 2021, 1864 (1) : 203 - 203
[47] Ipilimumab/nivolumab/pembrolizumabVarious toxicities: 2 case reports
Reactions Weekly, 2023, 1960 (1) : 248 - 248
[48] Atezolizumab/nivolumab/pembrolizumabVarious toxicities: 9 case reports
Reactions Weekly, 2020, 1806 (1) : 59 - 59
[49] Ipilimumab/nivolumab/pembrolizumabVarious toxicities: 3 case reports
Reactions Weekly, 2023, 1968 (1) : 183 - 183
[50] Ipilimumab/nivolumab/pembrolizumabVarious toxicities: 2 case reports
Reactions Weekly, 2018, 1715 (1) : 147 - 147

← 1 2 3 4 5 →